Attoub S, Moizo L, Sobhani I, Laigneau JP, Lewin MJ, Bado A (2001). „The H3 receptor is involved in cholecystokinin inhibition of food intake in rats”. Life Sci. 69 (4): 469—78. PMID11459437. doi:10.1016/S0024-3205(01)01138-9.
Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM (2004). „Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms”. J. Neurochem. 90 (6): 1331—8. PMID15341517. doi:10.1111/j.1471-4159.2004.02606.x.
Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (2004). „The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders”. Trends Pharmacol. Sci. 25 (12): 618—25. PMID15530639. doi:10.1016/j.tips.2004.10.003.
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP (2008). „Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.”. Pain. 138 (1): 61—78. PMID18164820. doi:10.1016/j.pain.2007.11.006.
Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005). „The histamine H3 receptor: from gene cloning to H3 receptor drugs”. Nature reviews. Drug discovery. 4 (2): 107—20. PMID15665857. doi:10.1038/nrd1631.
Arrang JM, Garbarg M, Schwartz JC (1983). „Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor”. Nature. 302 (5911): 832—7. PMID6188956. doi:10.1038/302832a0.
Attoub S, Moizo L, Sobhani I, Laigneau JP, Lewin MJ, Bado A (2001). „The H3 receptor is involved in cholecystokinin inhibition of food intake in rats”. Life Sci. 69 (4): 469—78. PMID11459437. doi:10.1016/S0024-3205(01)01138-9.
Rouleau A, Héron A, Cochois V, Pillot C, Schwartz JC, Arrang JM (2004). „Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms”. J. Neurochem. 90 (6): 1331—8. PMID15341517. doi:10.1111/j.1471-4159.2004.02606.x.
Passani MB, Lin JS, Hancock A, Crochet S, Blandina P (2004). „The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders”. Trends Pharmacol. Sci. 25 (12): 618—25. PMID15530639. doi:10.1016/j.tips.2004.10.003.
Medhurst SJ, Collins SD, Billinton A, Bingham S, Dalziel RG, Brass A, Roberts JC, Medhurst AD, Chessell IP (2008). „Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.”. Pain. 138 (1): 61—78. PMID18164820. doi:10.1016/j.pain.2007.11.006.
Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005). „The histamine H3 receptor: from gene cloning to H3 receptor drugs”. Nature reviews. Drug discovery. 4 (2): 107—20. PMID15665857. doi:10.1038/nrd1631.
Arrang JM, Garbarg M, Schwartz JC (1983). „Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor”. Nature. 302 (5911): 832—7. PMID6188956. doi:10.1038/302832a0.
Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW (2002). „Behavioral characterization of mice lacking histamine H3 receptors”. Mol. Pharmacol. 62 (2): 389—97. PMID12130692. doi:10.1124/mol.62.2.389.
pubmed.ncbi.nlm.nih.gov
Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. Journal of Pharmacology and Experimental Therapeutics. 2005 Jul;314(1):271-81. PMID15821027
Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochemical Pharmacology. 2004 September 1;68(5):933-45. PMID15294456